Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

In short

This is an Innovation Action under Horizon Europe. The budget is €20 million for about 3 grants of €7 million to €10 million each. It is paid as a lump sum, so you report results instead of costs. Submission opens on 10 February 2027. Deadline: 16 September 2027.

What the call wants to achieve

• Patients afflicted by lung, bowel, breast or prostate cancer [1] , will benefit from the outcomes of evidence-based, tailored, innovative, affordable and accessible diagnosis- and treatment-centred clinical research programmes by comprehensive cancer infrastructures [2] .
• Researchers, physicians, patient representatives, civil society, charities, foundations, insurance companies, SMEs and innovators [3] will seize opportunities to respectively co-create, support, upscale or commercialise outcomes of evidence-based, tailored, affordable and accessible clinical research programmes for (…)
• National and regional healthcare providers, healthcare payers, policymakers and authorities in European regions, EU Member States and Associated Countries have the evidence to engage in piloting, upscaling or implementing appropriate clinical research programmes for the diagnosis and treatment of patients afflicted by (…)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0, summarised. The official call text and its annexes decide eligibility, budget and deadlines.

Similar calls